The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer
Open accessAbstract
Histone modifications are thought to control the regulation of genetic programs in normal physiology and cancer. Methylation (mono-, di-, and tri-methylation) on histone H3 lysine (K) 27 induces transcriptional repression, and thereby participates in controlling gene expression patterns. Enhancer of zeste (EZH) 2, a methyltransferase and component of the polycomb repressive complex 2 (PRC2), plays an essential role in the epigenetic maintenance of the H3K27me3 repressive chromatin mark. Abnormal EZH2 expression has been associated with various cancers including breast cancer. Here, we discuss the contribution of EZH2 and the PRC2 complex in controlling the H3K27 methylation status and subsequent consequences on genomic instability and the cell cycle in breast cancer cells. We also discuss distinct molecular mechanisms used by EZH2 to suppress BRCA1 functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
The Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,514
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R. M., Chevalier, B., Johnstone, S. E., Cole, M. F., Isono, K.-I., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,268
Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G. A. B., Otte, A. P., Hayes, D. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933744100 · Cited by 1,649
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
Bracken, A. P., Dietrich, N., Pasini, D., Hansen, K. H., & Helin, K. (2006) · Genes & Development · doi:10.1101/gad.381706 · Cited by 1,257
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.
Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E., & Helin, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg542 · Cited by 1,196
Partitioning and Plasticity of Repressive Histone Methylation States in Mammalian Chromatin
Peters, A. H. F. M., Kubicek, S., Mechtler, K., O'Sullivan, R. J., Derijck, A. A. H. A., Perez-Burgos, L., Kohlmaier, A., Opravil, S., Tachibana, M., Shinkai, Y., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00477-5 · Cited by 1,152
E2F integrates cell cycle progression with DNA repair, replication, and G 2 /M checkpoints
Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R. A., & Dynlacht, B. D. (2002) · Genes & Development · doi:10.1101/gad.949802 · Cited by 1,125
Shen, X., Liu, Y., Hsu, Y.-J., Fujiwara, Y., Kim, J., Mao, X., Yuan, G.-C., & Orkin, S. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.016 · Cited by 1,021
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
Ku, M., Koche, R. P., Rheinbay, E., Mendenhall, E. M., Endoh, M., Mikkelsen, T. S., Presser, A., Nusbaum, C., Xie, X., Chi, A. S., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000242 · Cited by 1,009
Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity
Pasini, D., Bracken, A. P., Jensen, M. R., Denchi, E. L., & Helin, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600402 · Cited by 916
Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
Margueron, R., Li, G., Sarma, K., Blais, A., Zavadil, J., Woodcock, C. L., Dynlacht, B. D., & Reinberg, D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.11.004 · Cited by 884
Polycomb silencing mechanisms and the management of genomic programmes
Schwartz, Y. B., & Pirrotta, V. (2007) · Nature Reviews Genetics · doi:10.1038/nrg1981 · Cited by 868
Bachmann, I. M., Halvorsen, O. J., Collett, K., Stefansson, I. M., Straume, O., Haukaas, S. A., Salvesen, H. B., Otte, A. P., & Akslen, L. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5180 · Cited by 851
Cao, R., & Zhang, Y. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.020 · Cited by 812
Tachibana, M., Sugimoto, K., Fukushima, T., & Shinkai, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101914200 · Cited by 784
Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells
Ezhkova, E., Pasolli, H. A., Parker, J. S., Stokes, N., Su, I.-H., Hannon, G., Tarakhovsky, A., & Fuchs, E. (2009) · Cell · doi:10.1016/j.cell.2008.12.043 · Cited by 604
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Cao, Q., Yu, J., Dhanasekaran, S. M., Kim, J. H., Mani, R.-S., Tomlins, S. A., Mehra, R., Laxman, B., Cao, X., Yu, J., et al. (2008) · Oncogene · doi:10.1038/onc.2008.333 · Cited by 583
Pereira, J. D., Sansom, S. N., Smith, J., Dobenecker, M.-W., Tarakhovsky, A., & Livesey, F. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002530107 · Cited by 451
Chang, C.-J., Yang, J.-Y., Xia, W., Chen, C.-T., Xie, X., Chao, C.-H., Woodward, W. A., Hsu, J.-M., Hortobagyi, G. N., & Hung, M.-C. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.10.035 · Cited by 408
Ezhkova, E., Lien, W.-H., Stokes, N., Pasolli, H. A., Silva, J. M., & Fuchs, E. (2011) · Genes & Development · doi:10.1101/gad.2019811 · Cited by 357
Fiskus, W., Wang, Y., Sreekumar, A., Buckley, K. M., Shi, H., Jillella, A., Ustun, C., Rao, R., Fernandez, P., Chen, J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-213496 · Cited by 356
Suz12 binds to silenced regions of the genome in a cell-type-specific manner
Squazzo, S. L., O’Geen, H., Komashko, V. M., Krig, S. R., Jin, V. X., Jang, S.-W., Margueron, R., Reinberg, D., Green, R., & Farnham, P. J. (2006) · Genome Research · doi:10.1101/gr.5306606 · Cited by 316
Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis
Wang, L., Jin, Q., Lee, J.-E., Su, I.-H., & Ge, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000031107 · Cited by 295
Sewalt, R. G. A. B., van der Vlag, J., Gunster, M. J., Hamer, K. M., den Blaauwen, J. L., Satijn, D. P. E., Hendrix, T., van Driel, R., & Otte, A. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3586 · Cited by 221
RUNX3 Attenuates β-Catenin/T Cell Factors in Intestinal Tumorigenesis
Ito, K., Lim, A. C.-B., Salto-Tellez, M., Motoda, L., Osato, M., Chuang, L. S. H., Lee, C. W. L., Voon, D. C.-C., Koo, J. K. W., Wang, H., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.004 · Cited by 219
Gonzalez, M. E., Li, X., Toy, K., DuPrie, M., Ventura, A. C., Banerjee, M., Ljungman, M., Merajver, S. D., & Kleer, C. G. (2009) · Oncogene · doi:10.1038/onc.2008.433 · Cited by 195
Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation
Fujii, S., Ito, K., Ito, Y., & Ochiai, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800224200 · Cited by 193
Chi, X.-Z., Yang, J.-O., Lee, K.-Y., Ito, K., Sakakura, C., Li, Q.-L., Kim, H.-R., Cha, E.-J., Lee, Y.-H., Kaneda, A., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8097-8107.2005 · Cited by 189
Yang, X., Karuturi, R. K. M., Sun, F., Aau, M., Yu, K., Shao, R., Miller, L. D., Tan, P. B. O., & Yu, Q. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005011 · Cited by 164
Rao, Z.-Y., Cai, M.-Y., Yang, G.-F., He, L.-R., Mai, S., Hua, W., Liao, Y.-J., Deng, H.-X., Chen, Y., Guan, X., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq150 · Cited by 152
MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes
Fujii, S., Tokita, K., Wada, N., Ito, K., Yamauchi, C., Ito, Y., & Ochiai, A. (2011) · Oncogene · doi:10.1038/onc.2011.118 · Cited by 137
Ding, L., Erdmann, C. A., Chinnaiyan, A. M., Merajver, S. D., & Kleer, C. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4300 · Cited by 132
Histone methyltransferase G9a contributes to H3K27 methylation in vivo
Wu, H., Chen, X., Xiong, J., Li, Y., Li, H., Ding, X., Liu, S., Chen, S., Gao, S., & Zhu, B. (2010) · Cell Research · doi:10.1038/cr.2010.157 · Cited by 131
Puppe, J., Drost, R., Liu, X., Joosse, S. A., Evers, B., Cornelissen‐Steijger, P., Nederlof, P. M., Yu, Q., Jonkers, J., van Lohuizen, M., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2354 · Cited by 117
Gonzalez, M. E., DuPrie, M. L., Krueger, H., Merajver, S. D., Ventura, A. C., Toy, K. A., & Kleer, C. G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1933 · Cited by 112
FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
Du, J., Li, L., Ou, Z., Kong, C., Zhang, Y., Dong, Z., Zhu, S., Jiang, H., Shao, Z., Huang, B., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1396-3 · Cited by 90
EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development
Kunju, L. P., Cookingham, C., Toy, K. A., Chen, W., Sabel, M. S., & Kleer, C. G. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.8 · Cited by 73
Role of H3K27 Demethylases Jmjd3 and UTX in Transcriptional RegulationPreprint
Hübner, M. R., & Spector, D. L. (2010) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2010.75.020 · Cited by 68
Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma
Toll, A. D., Dasgupta, A., Potoczek, M., Yeo, C. J., Kleer, C. G., Brody, J. R., & Witkiewicz, A. K. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.03.004 · Cited by 67
Gong, Y. Y., Huo, L., Liu, P., Sneige, N., Sun, X., Ueno, N. T., Lucci, A., Buchholz, T. A., Valero, V., & Cristofanilli, M. (2011) · Cancer · doi:10.1002/cncr.26179 · Cited by 67
Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers.
Phillips, K. (2000) · PubMed · Cited by 66
Shukla, V., Coumoul, X., Cao, L., Wang, R.-H., Xiao, C., Xu, X., Andò, S., Yakar, S., LeRoith, D., & Deng, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4570 · Cited by 49
Epigenetics and reproduction and the developmental origins of health and disease
Aagaard-Tillery, K. M., Suter, M., Harris, A. C., Abramovici, A., & Cantu, J. (2010) · Animal Reproduction · Cited by 10
Role of H3K27 Demethylases Jmjd3 and UTX in Transcriptional RegulationPreprint
Hübner, M. R., & Spector, D. (2010) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2010.75.020r · Cited by 4
Cited by
Cooke, P. S., Nanjappa, M. K., Ko, C., Prins, G. S., & Hess, R. A. (2017) · Physiological Reviews · doi:10.1152/physrev.00018.2016 · Cited by 466
Nrf2 Transcription Factor Can Directly Regulate mTOR
Bendavit, G., Aboulkassim, T., Hilmi, K., Shah, S., & Batist, G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.760249 · Cited by 95
Martin-Mateos, R., De Assuncao, T. M., Arab, J. P., Jalan-Sakrikar, N., Yaqoob, U., Greuter, T., Verma, V. K., Mathison, A. J., Cao, S., Lomberk, G., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.09.005 · Cited by 73
Roles of histone H3K27 trimethylase Ezh2 in retinal proliferation and differentiation
Iida, A., Iwagawa, T., Baba, Y., Satoh, S., Mochizuki1, Y., Nakauchi, H., Furukawa, T., Koseki, H., Murakami, A., & Watanabe, S. (2015) · Developmental Neurobiology · doi:10.1002/dneu.22261 · Cited by 55
Metadata
- Authors
- Yoo, K. H., & Hennighausen, L.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2012
- Volume
- 8
- Issue
- 1
- Pages
- 59-65
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W2155990718
- Cited by
- 258
- References
- 46
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.